CO5160252A1 - Proceso para preparar secretagogos de hormonas del crecimiento - Google Patents

Proceso para preparar secretagogos de hormonas del crecimiento

Info

Publication number
CO5160252A1
CO5160252A1 CO00012732A CO00012732A CO5160252A1 CO 5160252 A1 CO5160252 A1 CO 5160252A1 CO 00012732 A CO00012732 A CO 00012732A CO 00012732 A CO00012732 A CO 00012732A CO 5160252 A1 CO5160252 A1 CO 5160252A1
Authority
CO
Colombia
Prior art keywords
secretagogs
prepare
growth hormones
alkyl
jpeg
Prior art date
Application number
CO00012732A
Other languages
English (en)
Spanish (es)
Inventor
Frank Robert Busch
Charles Kwok-Fung Chiu
Nathaniel Meltz Clifford
Ronald James Post
Peter Robert Rose
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of CO5160252A1 publication Critical patent/CO5160252A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
CO00012732A 1999-02-26 2000-02-23 Proceso para preparar secretagogos de hormonas del crecimiento CO5160252A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26

Publications (1)

Publication Number Publication Date
CO5160252A1 true CO5160252A1 (es) 2002-05-30

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00012732A CO5160252A1 (es) 1999-02-26 2000-02-23 Proceso para preparar secretagogos de hormonas del crecimiento

Country Status (43)

Country Link
US (2) US6541634B2 (enExample)
EP (2) EP1449842A1 (enExample)
JP (3) JP3437813B2 (enExample)
KR (2) KR100372063B1 (enExample)
CN (3) CN1515570A (enExample)
AP (1) AP1221A (enExample)
AR (2) AR029617A1 (enExample)
AT (1) ATE277944T1 (enExample)
AU (1) AU764122B2 (enExample)
BG (1) BG104175A (enExample)
BR (2) BRPI0017522B8 (enExample)
CA (1) CA2299495C (enExample)
CO (1) CO5160252A1 (enExample)
DE (1) DE60014212T2 (enExample)
DK (1) DK1031575T3 (enExample)
DZ (1) DZ3018A1 (enExample)
EA (1) EA003218B1 (enExample)
EE (1) EE200000193A (enExample)
ES (1) ES2226712T3 (enExample)
GT (1) GT200000018A (enExample)
HN (1) HN2000000021A (enExample)
HR (1) HRP20000103A2 (enExample)
HU (1) HUP0000907A3 (enExample)
ID (1) ID24861A (enExample)
IL (2) IL134599A (enExample)
IN (1) IN192352B (enExample)
IS (1) IS5380A (enExample)
MA (1) MA25072A1 (enExample)
NO (1) NO20000965L (enExample)
NZ (1) NZ503062A (enExample)
OA (1) OA11325A (enExample)
PA (1) PA8491201A1 (enExample)
PE (1) PE20001550A1 (enExample)
PL (1) PL338628A1 (enExample)
PT (1) PT1031575E (enExample)
SG (1) SG90096A1 (enExample)
SI (1) SI1031575T1 (enExample)
SK (1) SK284982B6 (enExample)
TN (1) TNSN00035A1 (enExample)
TR (1) TR200000536A2 (enExample)
TW (2) TW200718702A (enExample)
UA (1) UA70306C2 (enExample)
ZA (1) ZA200000888B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
EP1289526A4 (en) 2000-05-30 2005-03-16 Merck & Co Inc MELANOCORTIN RECEPTOR AGONISTS
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
TWI629982B (zh) 2013-05-28 2018-07-21 拉夸里亞創藥股份有限公司 多晶型形式
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法
WO2024217441A1 (zh) * 2023-04-21 2024-10-24 长春金赛药业有限责任公司 GHSR 1a激动剂、药物组合物及其制备方法和应用
CN119285632B (zh) * 2024-10-09 2026-08-11 威海中腾医药科技有限公司 一种基于酵母醇脱氢酶催化氧化的卡普瑞林中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5578593A (en) 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
BR9408019A (pt) 1993-11-09 1997-08-26 Merck & Co Inc Composto composição util para aumentar a produção endógena ou a liberaçao de hormonio do crescimento em ser humano ou um animal e para o tratamento da osteoporose processos para aumentar os niveis de hormônio do crescimento em um ser humano ou um animal e a eficácia de alimentação promover o crescimento aumentar a produçao de leite e melhorar a qualidade da carcaça de gado para tratar ou previnir uma condição selecionada para tratar osteoporose e para preparar um composto
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
AU2722297A (en) 1996-04-03 1997-10-22 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
US6251902B1 (en) 1997-06-25 2001-06-26 Pfizer Inc. Dipeptide derivatives as growth hormone secretagogues
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
UA64751C2 (uk) * 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)

Also Published As

Publication number Publication date
KR20020065455A (ko) 2002-08-13
TR200000536A2 (tr) 2000-09-21
TW200718702A (en) 2007-05-16
DZ3018A1 (fr) 2004-03-20
SK2302000A3 (en) 2000-11-07
EA200000172A2 (ru) 2000-08-28
BRPI0000967B8 (pt) 2021-12-07
AR053722A2 (es) 2007-05-16
BRPI0000967A (pt) 2001-09-11
HUP0000907A2 (en) 2001-03-28
JP2000247974A (ja) 2000-09-12
US20020002283A1 (en) 2002-01-03
DK1031575T3 (da) 2005-01-03
IL134599A (en) 2006-12-10
EE200000193A (et) 2000-10-16
EP1031575B1 (en) 2004-09-29
IL157103A (en) 2007-07-24
JP2003327585A (ja) 2003-11-19
TWI286142B (en) 2007-09-01
CN1515570A (zh) 2004-07-28
IN192352B (enExample) 2004-04-10
AU764122B2 (en) 2003-08-07
ATE277944T1 (de) 2004-10-15
EA200000172A3 (ru) 2000-10-30
PL338628A1 (en) 2000-08-28
GT200000018A (es) 2001-08-16
ID24861A (id) 2000-08-31
KR20010006698A (ko) 2001-01-26
SG90096A1 (en) 2002-07-23
HN2000000021A (es) 2001-02-02
PA8491201A1 (es) 2001-04-30
NO20000965D0 (no) 2000-02-25
CN1137891C (zh) 2004-02-11
JP3437813B2 (ja) 2003-08-18
US6673929B2 (en) 2004-01-06
CN1837205A (zh) 2006-09-27
OA11325A (en) 2003-10-27
JP4051314B2 (ja) 2008-02-20
AR029617A1 (es) 2003-07-10
BRPI0017522B1 (pt) 2013-09-24
JP2003261565A (ja) 2003-09-19
AU1947100A (en) 2000-08-31
UA70306C2 (en) 2004-10-15
BRPI0017522B8 (pt) 2021-05-25
ES2226712T3 (es) 2005-04-01
IL157103A0 (en) 2004-02-08
US6541634B2 (en) 2003-04-01
EP1031575A1 (en) 2000-08-30
IL134599A0 (en) 2001-04-30
US20030158414A1 (en) 2003-08-21
EA003218B1 (ru) 2003-02-27
BG104175A (bg) 2000-12-29
DE60014212T2 (de) 2005-12-15
BRPI0000967B1 (pt) 2012-06-12
ZA200000888B (en) 2001-08-23
PT1031575E (pt) 2004-11-30
HU0000907D0 (en) 2000-04-28
KR100372063B1 (ko) 2003-02-14
MA25072A1 (fr) 2000-10-01
BRPI0017522A2 (enExample) 2009-12-22
HRP20000103A2 (en) 2001-04-30
HUP0000907A3 (en) 2001-05-28
DE60014212D1 (de) 2004-11-04
PE20001550A1 (es) 2001-01-11
KR100361783B1 (ko) 2002-11-22
CN1270960A (zh) 2000-10-25
EP1449842A1 (en) 2004-08-25
CA2299495C (en) 2010-06-15
IS5380A (is) 2000-08-27
AP2000001754A0 (en) 2000-03-31
NZ503062A (en) 2001-07-27
SK284982B6 (sk) 2006-03-02
HK1030219A1 (en) 2001-04-27
CA2299495A1 (en) 2000-08-26
SI1031575T1 (en) 2005-02-28
AP1221A (en) 2003-11-03
TNSN00035A1 (fr) 2005-11-10
NO20000965L (no) 2000-08-28

Similar Documents

Publication Publication Date Title
CO5221115A1 (es) Nuevos compuestos fungicidas
CO5390047A1 (es) Derivados de uk-2a
CL2003002770A1 (es) Compuestos derivados de pirrol e imiddazol; composiciones farmaceuticas que los contienen; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de enfermedades que estan asociadas con la modulacion de los receptores a canabinoides
CO5140093A1 (es) Epotilonas c 21 modificadas
EG24902A (en) Pyrimidine compounds and pests controlling composition containing the same
ATE380818T1 (de) Piperazine-substituierte aryl-benzodiazepinen und ihre verwendung als dopaminrezeptor-antagonisten zur behandlung von psychose
CO5261616A1 (es) Inhibidores no peptidicos de la union celular dependientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
MY116761A (en) Novel spiroazabicyclic heterocyclic compounds.
ID29452A (id) 4-okso-1,4-dihidro-3-quinolinkarboksamida sebagai agen-agen antivirus
CO5261607A1 (es) Nuevo uso
CO5170512A1 (es) Derivados de tetrahidroquinolin piperidina
BR0112456A (pt) Compostos de piperidina para uso como inibidores de ccr-3
PT88206A (pt) Processo para a preparacao de derivados de 2-{(4-piperidinil)-metil}-1,2,3,4-tetrahidro-9h-pirido{3,4-b}indol e de composicoes farmaceuticas que os contem
CO5320590A1 (es) Metodo de preparacion de compuestos herbicidas de acido fenoxipropionico n-alquil-n-fluorofenilamida
BRPI0407841A (pt) inibidores heterocìclicos de quinase
PE20061490A1 (es) Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1
NZ332990A (en) oral pharmaceutical composition containing a H+, K+-atpase inhibitor having a extended blood plasma profile
PE20011008A1 (es) Derivados de pirimidina como inhibidores de ciclooxigenasa 2
CO5090829A1 (es) Compuestos organicos de la formula i, utiles como inhibido res de la proteina de transferencia de triglicerido microso mal y de la secrecion de la apolipoproteina b.
TW200643139A (en) π-conjugated compound having cardo structure, process for preparing same and use of same
CO5200762A1 (es) Preparacion de piperidin-4-onas sustituidas
CO5231155A1 (es) Benzoilciclohexanodionas substituidas
KR920012004A (ko) 광학 활성 1-아릴-알킬아민의 라세미화 방법
PT89643A (pt) Processo para a preparacao de derivados de 2-{(4-piperidinil)-metil}-1,2,3,4-tetrahidro-isoquinoleina e de composicoes farmaceuticas que os contem
NO20071100L (no) 5-jodtetrazoler